EXELON CORP (PEO.DE) Stock Analyst Ratings

Europe • Frankfurt Stock Exchange • FRA:PEO • US30161N1019

37.12 EUR
-0.12 (-0.32%)
Last: Feb 5, 2026, 07:00 PM
Buy % Consensus

71

ChartMill assigns a Buy % Consensus number of 71% to PEO.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 43.49. This target is 17.15% above the current price.
  • PEO.DE was analyzed by 24 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about PEO.DE.
  • In the previous month the buy percentage consensus was at a similar level.
  • PEO.DE was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
PEO.DE Historical Analyst RatingsPEO.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 37.1234.1043.2743.4951.81 - -8.13% 16.57% 17.15% 39.59%
PEO.DE Current Analyst RatingPEO.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2021-08-12 Mizuho Upgrade Underperform -> Neutral
2021-07-20 Morgan Stanley Maintains Overweight
2021-06-21 Morgan Stanley Maintains Overweight
2021-05-18 Morgan Stanley Maintains Overweight
2021-04-16 Morgan Stanley Maintains Overweight
2021-02-23 Credit Suisse Maintains Outperform
2021-02-18 Morgan Stanley Maintains Overweight

EXELON CORP / PEO.DE FAQ

What do analysts expect the price target to be for EXELON CORP (PEO.DE)?

24 analysts have analysed PEO.DE and the average price target is 43.49 EUR. This implies a price increase of 17.15% is expected in the next year compared to the current price of 37.12.


Can you provide the consensus rating for EXELON CORP stock?

The consensus rating for EXELON CORP (PEO.DE) is 70.8333 / 100 . This indicates that analysts generally have a positive outlook on the stock.